Latest Breaking News On - Immunology division - Page 1 : vimarsana.com

ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024

SAN DIEGO, Feb. 22, 2024 ARS Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic reactions.

United statesLaura oneillThomasb casaleJustin chakmaJonathan spergelPharmaceuticals incAllergy program at children hospital of philadelphiaAllergy programImmunology divisionInvestor dayInvestor contact

Research demonstrates that killer T cells can support tissue regeneration

Research demonstrates that killer T cells can support tissue regeneration
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Michael delacherLisa schmidleithnerMarkus feuererImmunology divisionLeibniz institute for immunotherapyExperimental medicineLeibniz instituteMalte simon

Diagnosis of 2-year-old s (very) rare syndrome fuels a warrior spirit | Education

WATERTOWN — Josiah J. Cabrera, 2, is no longer a medical mystery. That designation was finally lifted eight months ago, 21 months after his birth.

New yorkUnited statesEast syracuseOrange countyWatertown high schoolBelleville henderson central schoolSan diegoFred modellKatrinak brownJosiah autoinflammatoryMakenzie cabreraJosiahj cabreraHalm hoffmanJosiah raynaudMakenziee cabreraJefferson community college

Prevalence of asthma 9% among adults in Qatar : study

Prevalence of asthma 9% among adults in Qatar : study

United arab emiratesGulf statesDina isaifanHassan mobayedSergio crovellaLama soubraMaryam al nesfImmunology divisionHamad bin khalifa universityHamad medical corporationHealth care corporationQatar universityEnergy research institutePrimary health care corporationQatar environment

Bacterial toxin may trigger multiple sclerosis onset and relapse

A specific toxin-producing gut bacteria may be responsible for both triggering the onset of multiple sclerosis (MS) and ongoing disease activity, according to a new study led by a team of researchers at Weill Cornell Medicine and NewYork-Presbyterian.

United statesSan diegoDavid sanninoChristopher masonGregoryf sonnenbergJennifer lindenYinghua maHenryr erleTimothy vartanianPresbyterian weill cornell medical centerImmunology divisionResearch institute at weill cornell medicineUniversity of californiaJill roberts institute for researchDepartment of neurology at weill cornell medicineResearch institute